Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs

PHASE3TerminatedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Atrial Fibrillation
Interventions
DEVICE

Endoscopic Ablation System

Single ablation procedure with Endoscopic Ablation System

DRUG

Standard Anti-arrhythmic Drug (AAD) Therapy

Medication as prescribed by physician.

Trial Locations (18)

14627

Strong Memorial Hosptial - University of Rochester, Rochester

19096

University of Pennsylvania Hospital, Philadelphia

23507

Sentara Cardiovascular Research Institute, Norfolk

33462

Palm Beach Heart Research Institute, Atlantis

43210

Ohio State University, Columbus

46202

Indiana University, Krannert Institute of Cardiology, Indianapolis

48109

University of Michigan, Ann Arbor

77030

The Methodist Hospital, Houston

78705

Texas Cardiac Arrhythmia Research, Austin

85260

Arizona Arrhythmia Consultants, Scottsdale

94143

University of California at San Francisco, San Francisco

95819-3633

Mercy General Hospital, Sacramento

Unknown

St. John's Health Center, Santa Monica

Florida Hospital, Orlando

Genesis Medical Center, Davenport

William Beaumont Hospital, Royal Oak

St. Luke's-Roosevelt, New York

University of Virginia, Charlottesville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CardioFocus

INDUSTRY